Washington Trust CO Neurocrine Biosciences Inc Transaction History

Washington Trust CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$79.65 - $106.22 $634,571 - $846,254	-7,967 Closed	0 $0
Q2 2021 Aug 05, 2021	BUY	$89.43 - $102.27 $183,331 - $209,653	2,050 Added 34.65%	7,967 $775,000
Q1 2021 Apr 28, 2021	BUY	$87.57 - $119.4 $7,180 - $9,790	82 Added 1.41%	5,917 $575,000
Q4 2020 Feb 09, 2021	BUY	$86.91 - $108.33 $507,119 - $632,105	5,835 New	5,835 $559,000

628

94.4M

505K

343K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13.1B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Washington Trust CO, based on Form 13F filings with the SEC.

Stay updated on Washington Trust CO with notifications on news.